Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
NCT00380224
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
bifeprunox, olanzapine
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer